Similar articles

• [Cerebral dopaminergic mechanisms. Present status of the problem].

  Oules MJ, Boscredon J. Oules MJ, et al. Ann Med Psychol (Paris). 1979 Nov;137(9):925-9. Ann Med Psychol (Paris). 1979. PMID: 232829 Review. French. No abstract available.
• The effect of piribedil on body temperature in mice and rats.

  Kapturkiewicz Z, Sowińska H. Kapturkiewicz Z, et al. Pol J Pharmacol Pharm. 1977 Nov-Dec;29(6):609-18. Pol J Pharmacol Pharm. 1977. PMID: 600860
• [The search for compounds with dopaminergic activity. VII. Synthesis of piribedil analogs].

  Woliński J, Kujawa T, Prokopienko G, Rafalska B. Woliński J, et al. Acta Pol Pharm. 1988;45(3):206-9. Acta Pol Pharm. 1988. PMID: 3239429 Polish. No abstract available.
• [Acute hypotensive effect of a central dopaminergic agonist, piribedil, administered intravenously in the normotensive human].

  Ziegler M, Georgiadis G, Elghozi JL. Ziegler M, et al. Arch Mal Coeur Vaiss. 1984 Oct;77(11):1186-90. Arch Mal Coeur Vaiss. 1984. PMID: 6441537 Clinical Trial. French.
• [Stimulation of somatotropin hormone by piribedil, a dopaminergic agonist, in endogenous depression. Preliminary study].

  Guillaume R, Charles G, Mesters P, Schittecatte M, Wilmotte J. Guillaume R, et al. Acta Psychiatr Belg. 1988 Mar-Apr;88(2):153-61. Acta Psychiatr Belg. 1988. PMID: 2905110 Review. French.